Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Boundless Bio Announces Portfolio Prioritization And Runway Extension; Prioritizes BBI-355/BBI-825 Combination And BBI-940; Discontinues Current Arms Of BBI-355 In Potentiate Trial; To Evaluate BBI-355/BBI-825 Combination In 2025; Reduces Workforce By One-Third

Author: Benzinga Newsdesk | May 23, 2025 04:05pm

Posted In: BOLD